Clinical trial
Telmisartan in Haemodialysis Patients With Chronic Heart Failure
NCT00490958 · University of Campania Luigi Vanvitelli, Other · Completed
Key facts
| NCT number | NCT00490958 |
|---|---|
| Title | Telmisartan in Haemodialysis Patients With Chronic Heart Failure |
| Official title | Effects Of Telmisartan Added To Angiotensin Converting Enzyme Inhibitors On Mortality And Morbidity In Haemodialysed Patients With Chronic Heart Failure: A Double-Blind Placebo-Controlled Trial |
| Lead sponsor | University of Campania Luigi Vanvitelli, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Heart Failure, Congestive |
| Intervention type | Drug |
| Interventions | telmisartan |
| Enrollment | 351 |
| Start date | Jan 1, 1999 |
| Completion | Jun 1, 2005 |
| First posted | Jun 25, 2007 |
| Last update posted | Oct 17, 2008 |
| Countries | Italy |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: